129 related articles for article (PubMed ID: 24641421)
1. All-trans-retinoic acid promotes iodine uptake via up- regulating the sodium iodide symporter in medullary thyroid cancer stem cells.
Tang M; Hou YL; Kang QQ; Chen XY; Duan LQ; Shu J; Li SL; Hu XL; Peng ZP
Asian Pac J Cancer Prev; 2014; 15(4):1859-62. PubMed ID: 24641421
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
Mei D; Lv B; Chen B; Xiao S; Jiang J; Xie Y; Jiang L
PLoS One; 2017; 12(8):e0182835. PubMed ID: 28817605
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
Unterholzner S; Willhauck MJ; Cengic N; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2006 Jan; 91(1):69-78. PubMed ID: 16234306
[TBL] [Abstract][Full Text] [Related]
5. Effect of ligands of nuclear hormone receptors on sodium/iodide symporter expression and activity in breast cancer cells.
Tanosaki S; Ikezoe T; Heaney A; Said JW; Dan K; Akashi M; Koeffler HP
Breast Cancer Res Treat; 2003 Jun; 79(3):335-45. PubMed ID: 12846418
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
Zhang M; Guo R; Xu H; Zhang M; Li B
Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848
[TBL] [Abstract][Full Text] [Related]
7. [All-trans retinoic acid improves iodine uptake of thyroid cancer cells via repressing transcriptional activity of β-catenin].
Lan L; Deng W; Chen HL; Huo LL; Deng LL; Zhang GY; Luo Y
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):553-8. PubMed ID: 26902198
[TBL] [Abstract][Full Text] [Related]
8. Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.
Kogai T; Liu YY; Mody K; Shamsian DV; Brent GA
J Biol Chem; 2012 Jan; 287(5):3292-300. PubMed ID: 22157753
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
Spitzweg C; Scholz IV; Bergert ER; Tindall DJ; Young CY; Göke B; Morris JC
Endocrinology; 2003 Aug; 144(8):3423-32. PubMed ID: 12865321
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells.
Zheng X; Cui D; Xu S; Brabant G; Derwahl M
Int J Oncol; 2010 Aug; 37(2):307-15. PubMed ID: 20596658
[TBL] [Abstract][Full Text] [Related]
12. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
13. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
Heltemes LM; Hagan CR; Mitrofanova EE; Panchal RG; Guo J; Link CJ
Cancer Gene Ther; 2003 Jan; 10(1):14-22. PubMed ID: 12489024
[TBL] [Abstract][Full Text] [Related]
14. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
15. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
[TBL] [Abstract][Full Text] [Related]
17. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
Cancer Biother Radiopharm; 2007 Jun; 22(3):443-9. PubMed ID: 17679169
[TBL] [Abstract][Full Text] [Related]
18. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
Mitrofanova E; Unfer R; Vahanian N; Link C
Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
20. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
